The metabolic syndrome

被引:28
作者
Roberts, WC [1 ]
机构
[1] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX 75246 USA
关键词
D O I
10.1016/j.amjcard.2003.10.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:274 / 274
页数:1
相关论文
共 6 条
[1]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[2]   Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease - The ADMIT Study: A randomized trial [J].
Elam, MB ;
Hunninghake, DB ;
Davis, KB ;
Garg, R ;
Johnson, C ;
Egan, D ;
Kostis, JB ;
Sheps, DS ;
Brinton, EA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (10) :1263-1270
[3]   Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia [J].
Gagné, C ;
Gaudet, D ;
Bruckert, E .
CIRCULATION, 2002, 105 (21) :2469-2475
[4]   Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults [J].
Heymsfield, SB ;
Segal, KR ;
Hauptman, J ;
Lucas, CP ;
Boldrin, MN ;
Rissanen, A ;
Wilding, JPH ;
Sjöström, L .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (09) :1321-1326
[5]   The metabolic syndrome - Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 [J].
Park, YW ;
Zhu, SK ;
Palaniappan, L ;
Heshka, S ;
Carnethon, MR ;
Heymsfield, SB .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (04) :427-436
[6]   Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity [J].
Rössner, S ;
Sjöström, L ;
Noack, R ;
Meinders, AE ;
Noseda, G .
OBESITY RESEARCH, 2000, 8 (01) :49-61